Inhalt

R&D Landscape

Standard Content Module
The Research Location Austria is on the fast track. With a research ratio of 3.22% of its gross domestic product, our country invests much more than the EU average. More than 60 industry clusters and customized innovation funding programs ensure an optimal interaction between the business and scientific communities.
listen

Innovation has tradition in Austria

Austria looks back on a long history of world-famous inventions. Did you know that the sewing machine was invented by an Austrian, Josef Madersperger? Or the marine propeller by Josef Ressel? Not to forget the development of the Porsche sports car by Ferdinand Porsche or the pH-stable penicillin by the Tyrolian company Biochemie Kundl (today a Novartis subsidiary). Not only yesterday but today as well, many innovative ideas come from Austria.

More Chances through Research

Federal and provincial governments will invest a total of EUR 5.9 billion in 2023 in research and development. Additional, there are R&D expenditures of almost EUR 6.7 billion coming from Austrian companies.

The Austrian model of success creates optimal conditions for international companies such as BMW, Bosch, Infineon and Novartis which bundle their R&D activities and competence centers in Austria. Top-level research, innovative spin-offs, clusters and big players on the global marketplace ensure that inspiring ideas are turned into marketable products and services.

Accordingly, high-tech technologies “Made in Austria” are the basis for practical applications or intelligent data security systems. Cancer research, smart grids or intelligent electricity networks of the future complement traditionally strong areas such as mechanical engineering, vehicle manufacturing, environmental technologies, innovative materials and the metals industry, which serve as export-oriented technology providers.

The 47 competence centers encompassed in the Austrian funding initiative COMET (Competence Centers for Excellent Technologies) promote the cooperation between industry and science in a targeted manner with respect to leading edge technologies.

Accordingly, Big Pharma companies rely on the know-how of the Graz-based Research Center Pharmaceutical Engineering (RCPE) for pharmaceutical process and product development.

At Oncotyrol, the renowned competence center for cancer therapy in Innsbruck, new research findings in the field of genomics, proteomics and metabolomics will be transferred to clinical cancer medicine.

The Austrian Center for Medical Innovation and Technology (Acmit), a competence center in Wiener Neustadt specializing in the development of medical robotics, is opening up new perspectives for buttonhole surgery (minimally invasive surgery).

BEST - Bioenergy and Sustainable Technologies GmbH boasts several research facilities in Austria and successful innovations in environmentally-friendly energy generation from biomass.

You may find interesting news on the research location Austria on the ABA website.